The Clinical Investigation On The Improvement Of Malnutrition In CKD5 Phase Of Patients With Deficiency Of Spleen And Kidney Qi Deficiency

Objective: investigate on the malnutrition of Influence by using themethod of reinforcing spleen and kidney to improve the CKD5 phase ofchronic kidney disease with kidney qi deficiency.Methods: To meet the inclusion standard CKD5 non dialysis patients selected 60 patients with syndrome differentiation in patients with spleen and kidney qirandomly divided into study group and control group.The control group weretreated with conventional western medicine including high quality protein diet,lower blood pressure,lipid,redress renalanemia,regulating the balance of calcium and phosphorus,keeping water,electrolyte and acid-base equilibrium balance.Thestudy group given westernmedicine basic therapyand Yishen Jianpi Decoction.Two groups of treatment time is 6 months.watching the beforeand after treatment,Plasma albumin,Plasma prealbumin,hemoglobin,transferrin,TCM symptom scores,MIS score,And evaluation it.Result:(1)The effect on TCM symptom scores: the study group and the control group respectively for 6 months after,the study group aftertreatment,TCM symptom scores was compared with the previous fall,the difference was statistical significance(P<0.05);the control group aftertreatment,TCM symptom scores was compared with the previous fall,but the difference no statistical significance(P>0.05);after treatment between the two groups comparedstudy group and the control group,The study group was superior to the control group,The differences was statistically significant(P<0.05).(2)The effect of TCM symptoms: study group of TCM symptomsefficacy was 70%,control group of TCM symptomsefficacy was 43.3%,the difference was statistically significant(P<0.05).(3)The influenceof the comprehensive effect: the study group and the control group respectively for 6 months after,the study group comprehensiveeffcacy was16.7%,the control group comprehensiveeffcacy was 6.7%,the difference was statistically significant(P<0.05).(4)The effect on albumin(ALB): the study group and the control group respectively for 6 months after,The albumin levels in the control group and the study group were significantly improved,the difference was statistical significance(P<0.01);after treatment between the two groups compared study group and the control group of albumin,The differences was statistically significant(P<0.05).(5)The effect on Plasma albumin(PA): the study group and the control group respectively for 6 months after,The plasma albumin levels in the control group and the study group were significantly improved,the difference was statistical significance(P<0.05);after treatment between the two groups compared study group and the control group of Plasma albumin,The differences was statistically significant(P<0.05).(6)The effect onhemoglobin(HB): the study group and the control group respectively for 6 months after,The hemoglobin levels in the control group and the study group were significantly improved,the difference was statistical significance(P<0.05);after treatment between the two groups compared study group and the control group of hemoglobin,The differences was statistically significant(P<0.05).(7)The effect on transferrin(TF): the study group and the control group respectively for 6 months after,The transferrin levels in the control group and the study group were significantly improved.the difference was statistical significance(P<0.01);after treatment between the two groups compared study group and the control group of transferrin,The differences was statistically significant(P<0.05).(8)The effect on MIS scores: the study group and the control group respectively for 6 months after,the study group aftertreatment,MIS scores was compared with the previous fall,the difference was statistical significance(P<0.05);the control group aftertreatment,MIS scores was compared with the previous fall,but the difference no statistical significance(P>0.05);after treatment between the two groups compared study group and the control group of MIS scores,The differences was statistically significant(P<0.05).Conclusion:(1)Benefit Kidney spleen method in the treatment of CKD5 phase of non dialysis patients,can raise The level of ALB,PA,Hb,improvie malnutrition status and Renal anemia.(2)Benefit Kidney spleen method in the treatment of CKD5 phase of non dialysis patients,can raise The level of transferrin,decrease MIS scores,may improvie Micro-inflammatory state.(3)Benefit Kidney spleen method in the treatment of CKD5 phase of non dialysis patients,can raise TCM symptoms points to improvie the quality of life.